Literature DB >> 9666413

Early arthritis therapy: rationale and current approach.

K P Machold1, G Eberl, B F Leeb, V Nell, B Windisch, J S Smolen.   

Abstract

Rheumatoid arthritis (RA) is a disease that seriously affects patients' quality of life and may lead to disability or even premature death, despite the availability of effective treatments. Evidence suggests that delay of treatment may be the main contributing factor for poor outcome. Delay is caused primarily by the erroneous belief that the course of RA may be controlled in many cases by mild measures such as nonsteroidal antiinflammatory drugs, physiotherapy, and rest. While this may be true in a certain percentage of patients, many patients with RA progress to severe disability. To prevent progression of disease, early treatment of RA, particularly in patients at high risk, seems mandatory. Therefore, early arthritis clinics (EAC) have been established in a number of countries. We discuss the rationale for early intervention and our experiences in Austrian EAC.

Entities:  

Mesh:

Year:  1998        PMID: 9666413

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  9 in total

1.  The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Authors:  Josef S Smolen; Daniel Aletaha
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

2.  Patients with rheumatoid arthritis in clinical care.

Authors:  J S Smolen; D Aletaha
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

3.  Predictors of functional status in patients with early rheumatoid arthritis.

Authors:  L M Jansen; D van Schaardenburg; I E van Der Horst-Bruinsma; P D Bezemer; B A Dijkmans
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 4.  [Early diagnosis of rheumatoid arthritis].

Authors:  M Schneider; B Ostendorf; C H Specker
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

5.  [The regional network ADAPTHERA : Rheumatology care through coordinated cooperation: comprehensive, trans-sectoral, covering all health insurance. Initial results].

Authors:  A Schwarting; B Pfeiff; C Amberger; D Pick; M Hesse; M Jendro; J Engels; A Böttger; C Kuhn; J Majdandzic; W Ziese; M-L Stadelmann; F W Kessler; H Dinges; S Ultes-Kaiser; U Droste; M Schmalhofer; A Hazenbiller; M Rector; J Weinmann-Menke; K Triantafyllias; M Becker; M Ataian; M Lablans; F Ueckert; T Panholzer; M Blettner
Journal:  Z Rheumatol       Date:  2016-12       Impact factor: 1.372

6.  Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.

Authors:  V P K Nell; K P Machold; T A Stamm; G Eberl; H Heinzl; M Uffmann; J S Smolen; G Steiner
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

Review 7.  Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Authors:  P Emery; F C Breedveld; M Dougados; J R Kalden; M H Schiff; J S Smolen
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

Review 8.  [Biologicals in treatment of rheumatoid arthritis and other inflammatory arthropathies].

Authors:  Judith Sautner; Burkhard F Leeb
Journal:  Wien Med Wochenschr       Date:  2003

9.  Undifferentiated arthritis: a changing population who did not benefit from enhanced disease-modifying anti-rheumatic drug strategies-results from a 25 year longitudinal inception cohort.

Authors:  Marloes Verstappen; Xanthe M E Matthijssen; Annette H M van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2022-08-03       Impact factor: 7.046

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.